Next Generation Sequencing Testing (NGS)
CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
Buyer
NHS Blood and Transplant
Value
Not provided
Published
11 May 2026
Closes
20 Feb 2026
Procurement details
Source
Atamis NHS Projects
Region
United Kingdom
Procurement method
Not provided
Category
Not provided
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
No CPV codes are available for this public record.
Lots
Lot default Next Generation Sequencing Testing (NGS)
Value not provided
Next Generation Sequencing Testing (NGS) from NHS Blood and Transplant (unknown value) with deadline 20 Feb 2026.
Delivery: United Kingdom
Documents
Unlock document linkAtamis tender page
Not provided
Notice
Contains public sector information licensed under the Open Government Licence v3.0.